Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arjo Report Publication Announcement 2020

Apr 8, 2020

2881_rns_2020-04-08_a0fb4adb-f06a-4975-a2f4-e80d3cc5885a.pdf

Report Publication Announcement

Open in viewer

Opens in your device viewer

Press release Malmö, April 8, 2020

Arjo announces date of 2020 Q1 report and conference call

Arjo will issue its Q1 report for 2020 on Monday April 27 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO.

We invite fund managers, analysts and the media to participate in the conference call. Please see details below to join the conference.

Swedish dial-in number: +46 (0)8 5033 6574
UK: +44 (0)330 336 9125
USA: +1 323-794-2093
Participant passcode: 3046663

During the telephone conference, a presentation will be held. To access the presentation, please use this link:https://slideassist.webcasts.com/starthere.jsp?ei=1300315

Alternatively, use the following link to download the presentation: https://www.arjo.com/int/about-us/investors/reports--presentations/2020/

Agenda

07:45 Call in to the conference
08:00 Review of the Q1 report
08.30 Q&A
09.00 End of conference

A recorded version of the conference is accessible for 90 days via the following link: https://slideassist.webcasts.com/starthere.jsp?ei=1300315

For more information, please contact:

Kornelia Rasmussen, EVP Marketing Communications & Public Relations Tel: +46(0)10 335 4810 E-mail: [email protected]

Saloni Deva, Investor Relations & Corporate Communications Tel: +46 (0) 10 335 4867 Email: [email protected]

About Arjo

At Arjo, we are committed to improving the everyday lives of people affected by reduced mobility and age-related health challenges. With products and solutions that ensure ergonomic patient handling, personal hygiene, disinfection, diagnostics, and the effective prevention of pressure ulcers and venous thromboembolism, we help professionals across care environments to continually raise the standard of safe and dignified care. Arjo has approximately 6,000 employees worldwide and customers in over 100 countries. In 2019, Arjo sales amounted to SEK 8.9 billion. Arjo is listed on Nasdaq Stockholm and its head office is located in Malmö, Sweden. Everything we do, we do with people in mind. www.arjo.com